Detection and identification of potential biomarkers of breast cancer

Journal of Cancer Research and Clinical Oncology

Volumn 136, Issue 8, 2010, Pages 1243-1254

  Fan, Yuxia ^a   Wang, Jiachen ^a   Yang, Yang ^b   Liu, Qiuliang ^a   Fan, Yingzhong ^a   Yu, Jiekai ^c   Zheng, Shu ^c   Li, Mengquan ^a   Wang, Jiaxiang ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Biomarker; Breast cancer; LC MS MS; MALDI TOF MS; Proteomics; SELDI TOF MS

Indexed keywords

APOLIPOPROTEIN C1; COMPLEMENT COMPONENT C3A; PROTEIN; TUMOR MARKER; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE (NADP); PEPTIDE FRAGMENT; PLASMA PROTEIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER STAGING; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEOMICS; SENSITIVITY AND SPECIFICITY; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; UPREGULATION; AMINO ACID SEQUENCE; BLOOD; BREAST TUMOR; CHEMISTRY; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE VECTOR; GENETICS; MOLECULAR GENETICS; MORTALITY; PATHOLOGY; REFERENCE VALUE; SURVIVAL RATE;

AMINO ACID SEQUENCE; BLOOD PROTEINS; BREAST NEOPLASMS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COMPLEMENT C3A; FEMALE; GENE EXPRESSION PROFILING; GENETIC VECTORS; GLYCERALDEHYDE 3-PHOSPHATE DEHYDROGENASE (NADP+); HUMANS; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PEPTIDE FRAGMENTS; REFERENCE VALUES; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 77954592075     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-010-0775-1     Document Type: Article

References (32)

1. Agyei Frempong MT, Darko E, Addai BW (2008) The use of carbohydrate antigen (CA) 15-3 as a tumor marker in detecting breast cancer. Pak J Biol Sci 11:1945-1948
2. Belluco C, Petricoin EF, Mammano E, Facchiano F, Ross-Rucker S, Nitti D, Di Maggio C, Liu C, Lise M, Liotta LA, Whiteley G (2007) Serum proteomic analysis identifies a highly sensitive and specific discriminatory pattern in stage 1 breast cancer. Ann Surg Oncol 14:2470-2476
3. Bjorge L, Hakulinen J, Vintermyr OK, Jarva H, Jensen TS, Iversen OE, Meri S (2005) Ascitic complement system in ovarian cancer. Br J Cancer 92:895-905
4. Cherel P, Hagay C, Benaim B, De Maulmont C, Engerand S, Langer A, Talma V (2008) Mammographic evaluation of dense breasts: techniques and limits. J Radiol 89:1156-1168
5. De Gelder R, van As E, Tilanus-Linthorst MM, Bartels CC, Boer R, Draisma G, de Koning HJ (2008) Breast cancer screening: evidence for false reassurance? Int J Cancer 123:680-686
6. Ding J, Warren R, Warsi I, Day N, Thompson D, Brady M, Tromans C, Highnam R, EastonD(2008) Evaluating the effectiveness of using standard mammogram form to predict breast cancer risk: casecontrol study. Cancer Epidemiol Biomarkers Prev 17:1074-1081
7. Fang J, Dong Y, Williams TD, Lushington GH (2008) Feature selection in validating mass spectrometry database search results. J Bioinform Comput Biol 6:223-240
8. Grabiec M, Nowicki P, Walentowicz M, Grezlikowska U, Mierzwa T, Chmielewska W (2005) Role of Ca-125 in the differential diagnosis of adnexal mass in breast cancer patients. Ginekol Pol 76:371-376
9. Hansh SM, Pitteri SJ, Faca VM (2008) Mining the plasma proteome for cancer biomarkers. Nature 452:571-579
10. Hu Y, Zhang SZ, Yu JK, Liu J, Zheng S (2005a) SELDI-TOF-MS: the proteomics and bioinformatics approaches in the diagnosis of breast cancer. Breast 14:250-255
11. Hu Y, Zhang SZ, Yu JK, Liu J, Zheng S, Hu X (2005b) Diagnostic application of serum protein pattern and artificial neural network software in breast cancer. Ai Zheng 24:67-71
12. Hundt S, Haug U, Brenner H (2007) Blood markers for early detection of colorectal cancer: a systematic review. Cancer Epidemiol Biomarkers Prev 16:1935-1953
13. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ (2008) Cancer statistics, 2008. CA Cancer J Clin 58:71-96
14. Kroman NT, Grinsted P, Nielsen NS (2007) Symptoms and diagnostic work-up in breast cancer. Ugeskr Laeger 169:2980-2981
15. Laronga C, Becker S, Watson P, Gregory B, Cazares L, Lynch H, Perry RR, Wright GL Jr, Drake RR, Semmes OJ (2003) SELDITOF serum profiling for prognostic and diagnostic classification of breast cancers. Dis Markers 19:229-238
16. Lee IN, Chen CH, Sheu JC, Lee HS, Huang GT, Chen DS, Yu CY, Wen CL, Lu FJ, Chow LP (2006) Identification of complement C3a as a candidate biomarker in human chronic hepatitis C and HCV-related hepatocellular carcinoma using a proteomics approach. Proteomics 6:2865-2873
17. Li J, Zhang Z, Rosenzweig J, Wang YY, Chan DW (2002) Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin Chem 48:1296-1304
18. Liu D, Cao L, Yu J, Que R, Jiang W, Zhou Y, Zhu L (2008) Diagnosis of pancreatic adenocarcinoma using Protein Chip technology. Pancreatology 9:127-135
19. Luo J, Qian JH, Yu JK, Zheng S, Xie X, Lu WG (2008) Discovery of altered protein profiles in epithelial ovarian carcinogenesis by SELDI mass spectrometry. Eur J Gynaecol Oncol 29:233-238
20. Markiewski MM, Mastellos D, Tudoran R, De Angelis RA, Strey CW, Franchini S, Wetsel RA, Erdei A, Lambris JD (2004) C3a and C3b activation products of the third component of complement (C3) are critical for normal liver recovery after toxic injury. J Immunol 173:747-754
21. Matheny ME, Resnic FS, Arora N, Ohno-Machado L (2007) Effects of SVM parameter optimization on discrimination and calibration for post-procedural PCI mortality. J Biomed Inform 40:688-697
22. Maurya P, Meleady P, Dowling P, Clynes M (2007) Proteomic approaches for serum biomarker discovery in cancer. Anticancer Res 27:1247-1255
23. Redondo M, Rivas-Ruiz F, Guzman-Soler MC, Labajos C (2008) Monitoring indicators of health care quality by means of a hospital register of tumours. J Eval Clin Pract 14:1026-1030
24. Sahu A, Lambris JD (2001) Structure and biology of complement protein C3, a connecting link between innate and acquired immunity. Immunol Rev 180:35-48
25. Skytt A, Thysell E, Stattin P, Stenman UH, Antti H, Wikstrom P (2007) SELDI-TOF MS versus prostate specific antigen analysis of prospective plasma samples in a nested case-control study of prostate cancer. Int J Cancer 121:615-620
26. Somorjai RL, Dolenko B, Baumgartner R (2003) Class prediction and discovery using gene microarray and proteomicsmass spectroscopy data: curses, caveats, cautions. Bioinformatics 19:1484-1491
27. Song G, Ouyang G, Bao S (2005) The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med 9:59-71
28. Tomosugi N (2004) Discovery of disease biomarkers by ProteinChip system; clinical proteomics as noninvasive diagnostic tool. Rinsho Byori 52:973-979
29. Wang XD, Wang JQ (2004) A survey on support vector machines training and testing algorithms. Comput Eng Appl 13:75-79
30. Wang J, Zhang X, Ge X, Guo H, Xiong G, Zhu Y (2008) Proteomic studies of early-stage and advanced ovarian cancer patients. Gynecol Oncol 111:111-119
31. Zheng H, Luo RC (2005) Diagnostic value of combined detection of TPS, CA153 and CEA in breast cancer. Di Yi Jun Yi Da Xue Xue Bao 25:1293-1298
32. Zhu W, Michael CW (2007) WT1, monoclonal CEA, TTF1, and CA125 antibodies in the differential diagnosis of lung, breast, and ovarian adenocarcinomas in serous effusions. Diagn Cytopathol 35:370-375